These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8145889)

  • 21. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for biochemical abnormalities in urolithiasis patients.
    Orakzai N; Hanbury DC; Farrington K
    J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship of 3' vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis.
    Mossetti G; Rendina D; Viceconti R; Manno G; Guadagno V; Strazzullo P; Nunziata V
    Nephrol Dial Transplant; 2004 Sep; 19(9):2259-65. PubMed ID: 15213319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary stone disease in diabetes mellitus.
    Meydan N; Barutca S; Caliskan S; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):64-70. PubMed ID: 12745748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
    Ceylan K; Topal C; Erkoc R; Sayarlioglu H; Can S; Yilmaz Y; Dogan E; Algun E; Gonulalan H
    Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of magnesium intake to serum and urinary calcium and magnesium levels in Trinidadian stone formers.
    Anatol TI; Pinto Pereira L; Matthew J; Sawh L
    Int J Urol; 2005 Mar; 12(3):244-9. PubMed ID: 15828950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic evaluation of urolithiasis patients from eastern Croatia.
    Babić-Ivancić V; Avdagić SC; Serić V; Kontrec J; Tucak A; Füredi-Milhofer H; Marković M
    Coll Antropol; 2004 Dec; 28(2):655-66. PubMed ID: 15666597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [To what extent does a diet varying in calcium influence recurrent lithiasis in idiopathic hypercalciuria?].
    Peña JC
    Rev Invest Clin; 2002; 54(2):105-7. PubMed ID: 12053806
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients.
    Murayama T; Sakai N; Yamada T; Takano T
    Int J Urol; 2001 Oct; 8(10):525-31; discussion 532. PubMed ID: 11737477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary hyperparathyroidism in cases of urinary stone].
    Tajima A; Fujii K; Ohta N; Ohmi Y; Suzuki K; Aso Y
    Hinyokika Kiyo; 1984 Jul; 30(7):975-9. PubMed ID: 6507215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers.
    Pasch A; Frey FJ; Eisenberger U; Mohaupt MG; Bonny O
    Nephrol Dial Transplant; 2008 Aug; 23(8):2563-70. PubMed ID: 18398019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiology of urinary lithiasis].
    Joual A; Rais H; Rabii R; el Mrini M; Benjelloun S
    Ann Urol (Paris); 1997; 31(2):80-3. PubMed ID: 9245252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sarcoidosis and urolithiasis].
    Lancina Martín JA; García Freire C; Busto Castañón L; Picallo Sánchez J; González Martín M
    Arch Esp Urol; 1995 Apr; 48(3):234-9. PubMed ID: 7755429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metabolic evaluation at the time of the first renal lithiasis episode].
    del Valle EE; Spivacow FR; Zanchetta JR
    Medicina (B Aires); 1995; 55(1):69-74. PubMed ID: 7565040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recurrent oxalocalcium lithiasis. 2: Risk factors and prevention of recurrence of calcium urinary lithiasis].
    Réveillaud RJ; Daudon M
    Rev Prat; 1989 Feb; 39(4):317-23. PubMed ID: 2649970
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary tract stone disease.
    Teotia M; Teotia SP
    J Assoc Physicians India; 1984 Aug; 32(8):731-7. PubMed ID: 6392285
    [No Abstract]   [Full Text] [Related]  

  • 38. [Calcium-binding anions in urine of patients with recurrent calculi and in healthy controls. Results of a long-term study].
    Leskovar P
    Z Urol Nephrol; 1982 Sep; 75(9):635-44. PubMed ID: 7158097
    [No Abstract]   [Full Text] [Related]  

  • 39. Family history in stone disease: how important is it for the onset of the disease and the incidence of recurrence?
    Koyuncu HH; Yencilek F; Eryildirim B; Sarica K
    Urol Res; 2010 Apr; 38(2):105-9. PubMed ID: 20077110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for urinary tract calculi in Trinidad.
    Anatol T; Pinto Pereira L; Simeon D; Sawh L
    Trop Med Int Health; 2003 Apr; 8(4):348-53. PubMed ID: 12667155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.